Ellington Financial Inc. Operating Cash Flow increased by 96.7% to -$9.96M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 92.1%, from -$126.40M to -$9.96M. Over 2 years (FY 2023 to FY 2025), Operating Cash Flow shows a downward trend with a 95.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.00M | $14.66M | $32.93M | $48.41M | -$48.66M | -$43.35M | -$70.89M | -$78.95M | -$59.46M | -$88.60M | -$141.69M | -$140.78M | -$126.40M | -$210.52M | -$290.43M | -$298.11M | -$9.96M |
| QoQ Change | — | -58.1% | +124.6% | +47.0% | -200.5% | +10.9% | -63.5% | -11.4% | +24.7% | -49.0% | -59.9% | +0.6% | +10.2% | -66.6% | -38.0% | -2.6% | +96.7% |
| YoY Change | — | — | — | +38.3% | -247.8% | -189.5% | — | — | -22.2% | -104.4% | -99.9% | -78.3% | -112.6% | -137.6% | -105.0% | -111.8% | +92.1% |